September 9, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4081 companies with "abnormal" market making, 1267 companies with positive Friction Factors and 5028 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. EMISPHERE TECHNOLOGIES INC (NASDAQ:EMIS), ADVENTRX PHARMACEUTICALS INC (AMEX:ANX), SPHERIX INC (NASDAQ:SPEX), CLEVELAND BIOLABS INC (NASDAQ:CBLI), VANTAGE DRILLING CO (AMEX:VTG), ULTA SALON COSMETICS & FRAGR (NASDAQ:ULTA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     EMIS       $0.130       10.00%       61,222          55.04%       45,850          41.22%       15,372          1,182   
     ANX        $0.150       16.30%       1,176,842       35.41%       1,078,087       32.44%       98,755          6,584   
     SPEX       $1.300       96.30%       1,021,477       53.38%       862,394         45.07%       159,083         1,224   
     CBLI       $0.260       9.89%        160,020         56.11%       125,066         43.85%       34,954          1,344   
     VTG        $0.170       13.60%       1,182,876       32.06%       990,246         26.84%       192,630         11,331  
     ULTA       $8.740       14.63%       2,354,415       50.57%       2,252,226       48.37%       102,189         117

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows EMIS with a dollar gain Friday of $0.13000 and a Friction Factor of 1,182 shares. That means that it only took 1,182 more shares of buying than selling to move EMIS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

EMISPHERE TECHNOLOGIES INC (NASDAQ:EMIS) - Emisphere Technologies, Inc., a biopharmaceutical company, focuses on the delivery of therapeutic molecules and pharmaceutical compounds using its eligen technology. The eligen technology could be applied to the oral route of administration, as well as the other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal, or transdermal. The companys product pipeline includes Oral Salmon Calcitonin, which is in Phase III clinical trials for the treatment of osteoporosis and osteoarthritis; Oral Recombinant Parathyroid Hormone, which is in Phase I clinical trials for the treatment of osteoporosis; and Oral Heparin that is in Phase III clinical trials, as well as Oral Low Molecular Weight Heparin, which is in Phase I clinical trials for the treatment of cardiovascular diseases. Its products under development also comprise Oral Insulin, which is in Phase II clinical trials, as well as Oral Glucagon-Like Peptides, which is in Phase I clinical trials for the treatment of diabetes; Oral Recombinant Human Growth Hormone that is in Phase I clinical trials for the treatment of growth disorders; and Oral Acyclovir, an anti-viral compound that is in Phase I clinical trials. In addition, the companys product pipeline consists of Oral PYY 3-36, which is in Phase I clinical trials for treating obesity; Oral Cromolyn Sodium that is in Phase I clinical trials for the treatment of asthma/allergies; and Oral Gallium, a preclinical stage product candidate, for oncology treatment. Emisphere Technologies has collaboration agreements with Novartis Pharma AG; Roche; and Genta, Inc. The company was founded in 1985. It was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. The company is headquartered in Cedar Knolls, New Jersey.

ADVENTRX PHARMACEUTICALS INC (AMEX:ANX) - ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates for the treatment of cancer. Its lead product candidates include ANX-530, an emulsion formulation of chemotherapy drug vinorelbine to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, as well as to treat advanced or metastatic breast cancer; and ANX-514, an emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. The company was founded in 1995 is headquartered in San Diego, California.

SPHERIX INC (NASDAQ:SPEX) - Spherix Incorporated, together with its subsidiaries, operates as a scientific research company. It is developing D-tagatose that is in Phase 3 clinical trial for the treatment of type 2 diabetes. The company also provides scientific and strategic support for suppliers, manufacturers, distributors, and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides. In addition, it offers technical and regulatory consulting services to biotechnology and pharmaceutical companies. The company was founded in 1967 and is based in Bethesda, Maryland.

CLEVELAND BIOLABS INC (NASDAQ:CBLI) - Cleveland Biolabs, Inc. engages in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from radiation and other acute stresses. The companys products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and intestine; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, small molecules that are intended to destroy tumor cells by simultaneously targeting two regulators of apoptosis. Cleveland Biolabs has strategic alliance with The Cleveland Clinic Foundation; a research agreement with Roswell Park Cancer Institute to develop its cancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of approximately 1,000,000 compounds; and a cooperative research and development agreement with the Armed Forces Radiobiology Research Institute. The company was founded in 2003 and is headquartered in Buffalo, New York.

VANTAGE DRILLING CO (AMEX:VTG) - Vantage Drilling Company provides offshore contract drilling services to multinational oil and natural gas companies, government owned oil and natural gas companies, and independent oil and natural gas producers worldwide. It involves in contracting drilling units, related equipment, and work crews to drill oil and natural gas wells, as well as offers construction supervision services. As of March 8, 2010, the companys fleet included four ultra-premium jackup rigs, three ultra-deepwater drillships, and two deepwater semisubmersibles. Vantage Drilling Company is based in Houston, Texas.

ULTA SALON COSMETICS & FRAGR (NASDAQ:ULTA) - Ulta Salon, Cosmetics & Fragrance, Inc., a beauty retailer, provides prestige, mass, and salon products; and salon services in the United States. Its stores offer approximately 21,000 beauty products in various categories, which include cosmetics, such as products for the face, eyes, cheeks, lips, and nails; haircare, including shampoos, conditioners, styling products, and hair accessories; salon styling tools comprising hair dryers, curling irons, and flat irons; skincare, and bath and body, such as products for the face, hands, and body; fragrances for men and women; private label consisting of Ulta branded cosmetics, skincare, bath and body products, and haircare; and other products, including candles, home fragrance products, and other health and beauty products. As of January 30, 2010, the company operated 346 stores in 38 states. It also operates full-service salons in its stores. The company was founded in 1990 and is based in Bolingbrook, Illinois.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Like: 👍